Location · Indiana
Clinical trials recruiting in Indiana
433 recruiting studies have at least one site in Indiana; 119 accept healthy volunteers. Studies that need a specific condition are included too, so check each listing.
Want the research companies that run paid Phase 1 studies for healthy volunteers? Paid clinical trial companies in Indiana.
433 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
Incyte Corporation
- Location
- Indianapolis, IN + 65 other US sites
- Eligibility basics
- Ages 2–11
- Recruiting
Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease
VIVEX Biologics, Inc.
- Location
- New Castle, IN + 18 other US sites
- Eligibility basics
- Ages 22–85
- RecruitingPhase 1
Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease
Zydus Therapeutics Inc.
- Location
- Indianapolis, IN
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis
Beijing InnoCare Pharma Tech Co., Ltd.
- Location
- Indianapolis, IN + 13 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
Harmony Biosciences Management, Inc.
- Location
- Fort Wayne, IN + 39 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
COUR Pharmaceutical Development Company, Inc.
- Location
- Indianapolis, IN + 44 other US sites
- Eligibility basics
- Ages 12–35
- RecruitingPhase 2
Study of Resmetirom in Children and Adolescents With MASH
Madrigal Pharmaceuticals, Inc.
- Location
- Indianapolis, IN
- Eligibility basics
- Ages 6–17
- RecruitingPhase 2
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
ONL Therapeutics
- Location
- Carmel, IN + 55 other US sites
- Eligibility basics
- Ages 55+
- RecruitingPhase 3
A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
Pfizer
- Location
- Indianapolis, IN + 4 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 3
A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)
Takeda
- Location
- Indianapolis, IN + 9 other US sites
- Eligibility basics
- Up to age 17
- Recruiting
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
BrioHealth Solutions, Inc.
- Location
- Indianapolis, IN + 46 other US sites
- Eligibility basics
- Ages 18–100
- Recruiting
Assessing Connected-Health, Pressure-Monitoring Technology for Improving Compression Therapy in Venous Leg Ulcer Treatment
Feeltect Limited
- Location
- Fort Wayne, IN
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Eli Lilly and Company
- Location
- Indianapolis, IN + 28 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 4
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice…
Eli Lilly and Company
- Location
- Indianapolis, IN + 38 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
Novo Nordisk A/S
- Location
- Indianapolis, IN + 9 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
AstraZeneca
- Location
- Munster, IN + 53 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 3
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Bristol-Myers Squibb
- Location
- Indianapolis, IN + 26 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 2
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Cumberland Pharmaceuticals
- Location
- Indianapolis, IN + 17 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 1
A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
Verve Therapeutics, Inc.
- Location
- Indianapolis, IN + 9 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
AbbVie
- Location
- Indianapolis, IN + 11 other US sites
- Eligibility basics
- Ages 5–17
- RecruitingPhase 2/Phase 3
Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome
Quoin Pharmaceuticals
- Location
- Indianapolis, IN + 2 other US sites
- Eligibility basics
- Ages 14+
- RecruitingPhase 2
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Apollo Therapeutics Ltd
- Location
- Clarksville, IN + 24 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 1/Phase 2
LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)
Locate Bio Pty Ltd
- Location
- Fort Wayne, IN + 2 other US sites
- Eligibility basics
- Ages 22–80
- RecruitingPhase 3
A Study of Pitolisant in Patients With Prader-Willi Syndrome
Harmony Biosciences Management, Inc.
- Location
- Indianapolis, IN + 18 other US sites
- Eligibility basics
- Ages 6+